Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Cutter

Showing results (291-300 of 296) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 296 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.
The New England Journal of Medicine|April 1, 2022
Treatment for Mild Chronic Hypertension during PregnancyAlan T Tita, Jeff M Szychowski, Kim Boggess, et al.
Neurology|July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trialIkjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
The Lancet. Neurology|January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trialGil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The New England Journal of Medicine|August 11, 2016
Randomized Trial of Thymectomy in Myasthenia GravisGil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 18, 2024
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol, John M Jakicic, Wendy M Kohrt, et al.
Pageof 30

Showing results (291-300 of 296) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 296 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2017
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disabilityNicholas G LaRocca, Lynn D Hudson, Richard Rudick, et al.
The New England Journal of Medicine|April 1, 2022
Treatment for Mild Chronic Hypertension during PregnancyAlan T Tita, Jeff M Szychowski, Kim Boggess, et al.
Neurology|July 3, 2020
Minimal manifestation status and prednisone withdrawal in the MGTX trialIkjae Lee, Hui-Chien Kuo, Inmaculada B Aban, et al.
The Lancet. Neurology|January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trialGil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
The New England Journal of Medicine|August 11, 2016
Randomized Trial of Thymectomy in Myasthenia GravisGil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 18, 2024
Molecular Transducers of Physical Activity Consortium (MoTrPAC): human studies design and protocol, John M Jakicic, Wendy M Kohrt, et al.
Pageof 30